Confirmed Speakers Include:

Protect Against Counterfeiting, Protect Your Bottom Line, Protect Your Patients

"In a market where counterfeit drug sales are estimated to reach $75B by 2010 according to the World Health Organization (WHO), it is clear that drug counterfeiting is on the increase"

Counterfeit Drugs: Decisive and Global Action Is Needed EAASM 2008

Counterfeit drug sales are becoming increasingly costly to pharmaceutical manufacturers and patients alike. To tackle this problem there is currently much activity in the industry to increase supply chain security, reduce counterfeiting and ultimately protect patient safety and companies’ bottom lines. Many of these key industry players will gather at Pharma IQ’s Serialisation & Traceability Conference 2010, where we will explore the following topics to help you achieve a smooth transition to mass serialisation, keep apace of the rapidly evolving authentication, serialisation and track and trace systems in order to reduce counterfeiting and remain competitive.

Worldwide industry representatives will share insights on topics including:

  • Emerging legislation on serialisation and coding across Europe
  • Legislation and Regulatory Standards set to tackle counterfeiting
  • Implications of the EU Draft Directive
  • Update on the EDQM Track & Trace Project
  • Understand what the EU Pharma Package will mean for you with the European Alliance for Safer Medicines
  • Achieving harmonisation in coding standards across the globe with GS1
  • Future Potential of mass serialisation and its incorporation into long term Supply Chain Security Strategies
  • Insights into Royal Pharmaceutical Society of Great Britain’s Campaign on Track & Trace
  • Compulsory Safety Features: Should They Be Extended Only to High Risk Medicines on a risk-assessed basis or should all medicinal products comply?
  • Optimal serialisation and track and trace approaches from countries already enforcing Unique Serial Numbers by law
  • Cost effective supply chain security: assessment of the degree of Security that should be enforced as a proposed compulsory security baseline
  • Outcomes and conclusions from the EFPIA Pilot Trials and future activities at EFPIA to fight counterfeiting
  • Creating anti-counterfeiting technology that cannot be replicated: covert and overt security features
  • 2D Data matrix versus RFID tags
  • Tamper evident packaging
  • Point of sale verification methods
  • Pharmacist’s perspective on serialisation and authentication: strategies to successful authentication

TESTIMONIALS

What your peers think about Pharma IQ’s supply chain series…

Very interesting-networking allowed me to meet people dealing with the same problematic I face every day. Sharing experience is very valuable and help analysing from another point of view.
Myriam Rey, UCB Farchim SA
Sponsors Media Partners
Sponsor _media

[ Register Now ]